Healthcare & Life Sciences

Beyond bureaucracy, a federal push for bilingual services aims to dismantle linguistic barriers, impacting health equity for minority communities across Canada.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A new partnership between evermore and Vallarta Supermarkets isn't just about groceries; it's about using tech to deliver health equity with cultural dignity.

One company's move to standardize a traditional remedy highlights a key strategy for winning trust and market share in the booming wellness industry.

NMI launches Business Capital, an embedded lending tool giving healthcare providers fast access to funds. Is this the lifeline the industry needs?

Allbirds co-founder Joey Zwillinger is applying consumer tech disruption to women's health. Can Biologica's science-backed model reshape a stagnant market?

In post-acute care, is training enough? A new digital platform aims to verify caregiver skills at the bedside, tackling both compliance and care quality.

Facing federal overhaul and public outcry, top organizations pledge reform. Can innovation and transparency fix a broken system and save thousands of lives?

A new study reveals a simple dietary change—swapping carb snacks for tree nuts—can curb cravings for junk food and improve health in young adults.

A landmark demonstration of 'unhackable' quantum communication on a live network signals a paradigm shift for protecting sensitive healthcare data.

iCIMS is #1 in the booming ATS market, but its real advantage isn't just AI. It's a validated, responsible approach that's winning over enterprise clients.

With its 2026 Investor Day nearing, PHINIA aims to prove its dual-path strategy is the key to powering a diverse, carbon-conscious industrial future.

Eli Lilly's takeover of Adverum signals a major push into ocular gene therapy. Can a one-time injection for vision loss disrupt a multi-billion dollar market?

A startup claims to solve AI's 95% pilot failure rate with a self-improving engine. We analyze if this is the key to unlocking true enterprise AI.

New data shows flat 2026 raises for healthcare workers and a strategic pay gap, while AI's promised workforce revolution is still waiting in the wings.

A new report on AI in the energy sector reveals a critical truth for medicine: general-purpose AI is not ready for high-stakes decisions without human experts.

Target RWE's strategic hire of NoviSci co-founder Alan Brookhart signals a major push to master regulatory-grade real-world evidence. What does this mean?

PERIOD. appoints Jennifer Herrera as its new ED. How will her background in national advocacy and grassroots organizing reshape the fight for menstrual equity?

Insiders at the newly independent Magnum Ice Cream Company show major confidence with multi-million-euro share buys following its spin-off from Unilever.